Clinical Microbiology and Infectious Diseases--13th European Congress: new therapies. 10-13 May, Glasgow, UK.
Gravenstede
Sarah
S
Thomson Current Drugs, London, UK. sarah.gravenstede@current-drugs.com
D000818:Animals; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use; D003141:Communicable Diseases / Q000188:drug therapy; D000529:Complementary Therapies; D006801:Humans; D008829:Microbiology; D015394:Molecular Structure; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000935:Antifungal Agents; D013792:Thalidomide